Treatment Approaches for Posttraumatic Stress Disorder Derived From Basic Research on Fear Extinction.
Jessica L Maples-Keller, Laura Watkins, Natalie Hellman, Nathaniel L Phillips, Barbara O Rothbaum
Biological psychiatry February 15, 2025 DOI: 10.1016/j.biopsych.2024.07.010 via PubMed
Summary
AI-generated from the abstractTreatment approaches for posttraumatic stress disorder (PTSD) based on fear conditioning and extinction models are reviewed. Fear extinction provides a translational model linking basic research in nonhuman animals to human treatments such as prolonged exposure therapy. Cognitive aspects of extinction, including consolidation and reconsolidation, are discussed along with behavioral and pharmacological strategies for preventing and treating chronic PTSD. Augmentation strategies reviewed include disrupting noradrenergic processes, NMDA receptor medications, physical exercise, cannabinoids, estradiol, dexamethasone, yohimbine, losartan, dopamine, and MDMA, with evidence for their efficacy in human samples. Limitations and future directions are also addressed.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Interventions | Prolonged exposure therapy physical exercise cannabinoids estradiol dexamethasone yohimbine losartan dopamine MDMA |
| Topics | PTSD |
| Keywords | Combination treatment Exposure therapy Fear extinction Translational PTSD Treatment |
| Citations | 12 |
| Key finding | Fear extinction models offer a translational opportunity to improve PTSD treatment, but the literature has limitations and challenges. |
Abstract
This brief review article will describe treatment approaches for posttraumatic stress disorder (PTSD) based on findings from basic research. The focus of this review will be fear conditioning and extinction models, which provide a translational model of PTSD that can help translate basic research in nonhuman animals through well-controlled trials confirming the efficacy of treatment approaches in humans with PTSD such as prolonged exposure therapy. Specific cognitive aspects of fear extinction processes, including consolidation and reconsolidation, are reviewed along with behavioral and pharmacological treatment strategies based on basic research in these areas including attempts to prevent the development of PTSD as well as the treatment of chronic PTSD. Pharmacological, behavioral, and device-based augmentation strategies of PTSD treatment based in basic science findings are reviewed, including those that disrupt noradrenergic receptor processes, medications that act on NMDA receptors, physical exercise, cannabinoids, estradiol, dexamethasone, yohimbine, losartan, dopamine, and MDMA, along with the evidence for their efficacy in human clinical samples. While fear extinction provides an exciting translational opportunity to improve PTSD based on basic science findings, we review limitations and challenges of the extant literature as well as future directions.